ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Current Medication Trendsand Global Impact on Neurodegenerative Disorders

Journal: Journal of Pharmaceutics & Pharmacology (Vol.6, No. 1)

Publication Date:

Authors : ; ;

Page : 01-09

Keywords : Neurodegenerative disorders; Parkinson; Alzheimer; Depression; AYUSH medication system;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Neurodegenerative disorders are the medical condition characterized by destruction in neuronal cells, abruption of neuronal activity and distinct involvement of the functional movement. The main neuronal disorders like Parkinson and Alzheimer disease are caused by environmental and genetic influences associated with accumulation of abnormal protein aggregation, which leads to inflammation as well as oxidative stress in the central nervous system. The AYUSH medication system considerably accepted by health-care professionals played a critical role since a decade to manage the elevated factors and continuously improving lifestyle for good survival of the patients. In which allopathic and ayurvedic medications have been precisely introduced for the management of disorders and regain of neuronal function. Unani and Siddha medicines have been widely used since ancient time and found as significantly reliving the sign and symptoms of neurodegenerative disorders, while yoga plays a perfect role for the management of these disorders. Regular yoga practice may relax the mind and calms the brain; reduces headache, fatigue and cures insomnia; increases blood circulation and maintain proper supply of oxygen to the lungs and detoxifies the internal organs. Thus, yoga plays a promising role in the improvement of mental health, releases stress, fatigue, depression and tension and also stimulating blood circulation in the brain. Finally it was concluded that, the AYUSH medication system highly accepted for reliving the neuronal complications and managing all elevated parameters in patients suffering from neuronal disorders.

Last modified: 2019-01-02 15:11:27